Overview of Health Complexity and the Interaction Between Physical and Behavioral Health Conditions

  • Roger G. Kathol
  • Rachel L. Andrew
  • Michelle Squire
  • Peter J. Dehnel
Chapter

Chapter Objectives

  • To define “health complexity” and the importance of medical and “behavioral health” information in value-based, integrated case management.

  • To describe the adverse interaction of physical and behavioral health disorders in adults/elderly and children/youth with health complexity.

  • To discuss the difficulty in delivering concurrent and coordinated treatment for physical and behavioral health disorders and their impact on health and cost outcomes.

  • To summarize the potential value of physical and behavioral health service integration and corresponding value-based integrated case management.

Keywords

Health complexity Care delivery integration Value-based integrated case management Medical and behavioral interaction Independent behavioral health delivery Health and cost outcomes 

References

  1. 1.
    Kathol RG, Patel K, Sacks L, Sargent S, Melek SP. The role of behavioral health services in accountable care organizations. Am J Manag Care. 2015;21(2):e95–8.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Kathol RG, Knutson KH, Dehnel PJ. Physician’s guide: understanding and working with integrated case managers. Cham: Springer; 2016. p. xv. 343 pages.CrossRefGoogle Scholar
  3. 3.
    Grant RW, Ashburner JM, Hong CS, Chang Y, Barry MJ, Atlas SJ. Defining patient complexity from the primary care physician’s perspective: a cohort study. Ann Intern Med. 2011;155(12):797–804.CrossRefPubMedCentralGoogle Scholar
  4. 4.
    Grembowski D, Schaefer J, Johnson KE, Fischer H, Moore SL, Tai-Seale M, et al. A conceptual model of the role of complexity in the care of patients with multiple chronic conditions. Med Care. 2014;52(Suppl 3):S7–S14.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Zullig LL, Whitson HE, Hastings SN, Beadles C, Kravchenko J, Akushevich I, et al. A systematic review of conceptual frameworks of medical complexity and new model development. J Gen Intern Med. 2016;31(3):329–37.CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Neff JM, Clifton H, Popalisky J, Zhou C. Stratification of children by medical complexity. Acad Pediatr. 2015;15(2):191–6.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Simon TD, Cawthon ML, Stanford S, Popalisky J, Lyons D, Woodcox P, et al. Pediatric medical complexity algorithm: a new method to stratify children by medical complexity. Pediatrics. 2014;133(6):e1647–54.CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Services USDoHaH. The National Survey of Children with Special Health Care Needs Chartbook 2009–2010. In: Health Resources and Services Administration MaCHB. Rockville, MD: U.S. Department of Health and Human Services; 2013. p. 1–110.Google Scholar
  9. 9.
    Chan T, Rodean J, Richardson T, Farris RW, Bratton SL, Di Gennaro JL, et al. Pediatric critical care resource use by children with medical complexity. J Pediatr. 2016;177:197–203.e1.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    McKissick HD, Cady RG, Looman WS, Finkelstein SM. The impact of telehealth and care coordination on the number and type of clinical visits for children with medical complexity. J Pediatr Health Care. 2017;31:452.CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Stiefel FC, Huyse FJ, Sollner W, Slaets JP, Lyons JS, Latour CH, et al. Operationalizing integrated care on a clinical level: the INTERMED project. Med Clin North Am. 2006;90(4):713–58.CrossRefPubMedCentralGoogle Scholar
  12. 12.
    de Jonge P, Huyse FJ, Slaets JP, Sollner W, Stiefel FC. Operationalization of biopsychosocial case complexity in general health care: the INTERMED project. Aust N Z J Psychiatry. 2005;39(9):795–9.CrossRefPubMedCentralGoogle Scholar
  13. 13.
    Meller W, Specker S, Schultz P, Kishi Y, Thurber S, Kathol R. Using the INTERMED complexity instrument for a retrospective analysis of patients presenting with medical illness, substance use disorder, and other psychiatric illnesses. Ann Clin Psychiatry. 2015;27(1):38–43.PubMedPubMedCentralGoogle Scholar
  14. 14.
    de Jonge P, Huyse FJ, Stiefel FC. Case and care complexity in the medically ill. Med Clin North Am. 2006;90(4):679–92.CrossRefPubMedCentralGoogle Scholar
  15. 15.
    Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med. 2009;151(3):203–5.CrossRefPubMedCentralGoogle Scholar
  16. 16.
    The Concentration of Health Care Spending [Internet]. National Institute for Health Care Management Foundation. 2012 [cited January 2017].Google Scholar
  17. 17.
    Zuvekas SH, Cohen JW. Prescription drugs and the changing concentration of health care expenditures. Health Aff (Millwood). 2007;26(1):249–57.CrossRefGoogle Scholar
  18. 18.
    Monheit AC. Persistence in health expenditures in the short run: prevalence and consequences. Med Care. 2003;41(7 Suppl):III53–64.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Blumenthal D, Abrams MK. Tailoring complex care management for high-need, high-cost patients. JAMA. 2016;316(16):1657–8.CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Barbosa C, Cowell A, Bray J, Aldridge A. The cost-effectiveness of alcohol screening, brief intervention, and referral to treatment (SBIRT) in emergency and outpatient medical settings. J Subst Abuse Treat. 2015;53:1–8.CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Jackson H, Mandell K, Johnson K, Chatterjee D, Vanness DJ. Cost-effectiveness of injectable extended-release naltrexone compared with methadone maintenance and buprenorphine maintenance treatment for opioid dependence. Subst Abus. 2015;36(2):226–31.CrossRefPubMedCentralGoogle Scholar
  22. 22.
    Laramee P, Brodtkorb TH, Rahhali N, Knight C, Barbosa C, Francois C, et al. The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model. BMJ Open. 2014;4(9):e005376.CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Parthasarathy S, Weisner CM. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample. Drug Alcohol Depend. 2005;80(2):231–40.CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352(24):2515–23.CrossRefPubMedCentralGoogle Scholar
  25. 25.
    Wang PS, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, Borges G, Bromet EJ, et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet. 2007;370(9590):841–50.CrossRefPubMedCentralGoogle Scholar
  26. 26.
    Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291(21):2581–90.CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Wang PS, Demler O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am J Public Health. 2002;92(1):92–8.CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629–40.CrossRefPubMedCentralGoogle Scholar
  29. 29.
    Kathol R, McAlpine D, Kishi Y, Spies R, Meller W, Bernhardt T, et al. General medical and pharmacy claims expenditures in users of behavioral health services. J Gen Intern Med. 2005;20(2):160–7.CrossRefPubMedCentralGoogle Scholar
  30. 30.
    Kathol RG, Degruy F, Rollman BL. Value-based financially sustainable behavioral health components in patient-centered medical homes. Ann Fam Med. 2014;12(2):172–5.CrossRefPubMedCentralGoogle Scholar
  31. 31.
    Melek S, Norris DT, Paulus J. Economic impact of integrated medical-behavioral healthcare: implications for psychiatry. Arlington VA: American Psychiatric Association; 2014.Google Scholar
  32. 32.
    Kathol RG, Melek SP, Sargent S, Sasks L, Patel KK. Chapter 11. Non-traditional mental health and substance use disorder services as a core part of health in CINs and ACOs. In: KRT Y, Bohn J, Konschak C, editors. Clinical integration: population health and accountable care. 3rd ed. Virginia Beach, VA: Convurgent Publishing, LLC; 2015.Google Scholar
  33. 33.
    Scott KM, Lim C, Al-Hamzawi A, Alonso J, Bruffaerts R, Caldas-de-Almeida JM, et al. Association of mental disorders with subsequent chronic physical conditions: world mental health surveys from 17 countries. JAMA Psychiat. 2016;73(2):150–8.CrossRefGoogle Scholar
  34. 34.
    Walker ER, Druss BG. A public health perspective on mental and medical comorbidity. JAMA. 2016;316(10):1104–5.CrossRefPubMedCentralGoogle Scholar
  35. 35.
    Domino ME, Beadles CA, Lichstein JC, Farley JF, Morrissey JP, Ellis AR, et al. Heterogeneity in the quality of care for patients with multiple chronic conditions by psychiatric comorbidity. Med Care. 2014;52(Suppl 3):S101–9.CrossRefPubMedCentralGoogle Scholar
  36. 36.
    Scott D, Burke K, Williams S, Happell B, Canoy D, Ronan K. Increased prevalence of chronic physical health disorders in Australians with diagnosed mental illness. Aust N Z J Public Health. 2012;36(5):483–6.CrossRefPubMedCentralGoogle Scholar
  37. 37.
    Jones DR, Macias C, Barreira PJ, Fisher WH, Hargreaves WA, Harding CM. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv. 2004;55(11):1250–7.CrossRefPubMedCentralGoogle Scholar
  38. 38.
    Huyse F, Stiefel F. In: Huyse F, Stiefel F, editors. Medical clinics of North America: integrated care for the complex medically ill. Philadelphia, PA: Elsevier; 2006.Google Scholar
  39. 39.
    Huyse F, Stiefel F. Jonge Pd. Identifiers, or “red flags,” of complexity or need for integrated care. In: Huyse F, Stiefel F, editors. Medical clinics of North America: integrated care for the complex medically ill, vol. 90. New York, NY: Elsevier; 2006. p. 703–12.Google Scholar
  40. 40.
    Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.CrossRefPubMedCentralGoogle Scholar
  41. 41.
    McIntyre RS, Konarski JZ, Soczynska JK, Wilkins K, Panjwani G, Bouffard B, et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv. 2006;57(8):1140–4.CrossRefPubMedCentralGoogle Scholar
  42. 42.
    Noritz G, Madden M, Roldan D, Wheeler TA, Conkol K, Brilli RJ, et al. A population intervention to improve outcomes in children with medical complexity. Pediatrics. 2017;139(1):pii: e20153076.CrossRefGoogle Scholar
  43. 43.
    Kathol R, Perez R, Cohen J. The integrated case management manual: assisting complex patients regain physical and mental health. 1st ed. New York, NY: Springer; 2010. p. 500+.Google Scholar
  44. 44.
    Rosenheck RA, Druss B, Stolar M, Leslie D, Sledge W. Effect of declining mental health service use on employees of a large corporation. Health Aff (Millwood). 1999;18(5):193–203.CrossRefGoogle Scholar
  45. 45.
    Thomas MR, Waxmonsky JA, Gabow PA, Flanders-McGinnis G, Socherman R, Rost K. Prevalence of psychiatric disorders and costs of care among adult enrollees in a Medicaid HMO. Psychiatr Serv. 2005;56(11):1394–401.CrossRefPubMedCentralGoogle Scholar
  46. 46.
    Huang Y, Wei X, Wu T, Chen R, Guo A. Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis. BMC Psychiatry. 2013;13:260.CrossRefPubMedCentralGoogle Scholar
  47. 47.
    Egede LE. Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care. 2004;27(7):1751–3.CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Roger G. Kathol
    • 1
  • Rachel L. Andrew
    • 2
  • Michelle Squire
    • 3
  • Peter J. Dehnel
    • 4
  1. 1.Cartesian Solutions, Inc.™ and University of MinnesotaBurnsvilleUSA
  2. 2.Premera Blue Cross Mountlake TerraceUSA
  3. 3.ManahawkinUSA
  4. 4.Twin Cities Medical SocietyEdinaUSA

Personalised recommendations